Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction

Circulation. Heart Failure
Thanh Trung PhanMichael Frenneaux

Abstract

This study assessed the chronotropic response to exercise and heart rate (HR) recovery after exercise in a carefully phenotyped group of patients with heart failure with preserved left ventricular ejection fraction (HfpEF) and a control group of similar age and gender distribution. We studied 41 patients with HfpEF, 41 healthy controls, and 16 hypertensive controls. None were taking HR-limiting medications. All study participants had clinical examination, 12-lead ECG, pulmonary function test, echocardiogram, and metabolic exercise test with HR monitoring throughout exercise. Chronotropic response was measured by the percentage of the HR reserve used during maximal exercise and the peak exercise HR as a percentage of predicted maximal HR. Patients with HfpEF were generally women (70%), overweight, aged 69+/-8 years. Controls were of similar gender (63%) and age (67+/-6 years). Patients with HfpEF had significantly reduced peak VO(2) compared with controls (20+/-4 mL kg(-1) min(-1) versus 31+/-6 mL kg(-1) min(-1), P<0.001) and greater minute ventilation-carbon dioxide production relationship (V(E)/V(CO2)) slope) (33+/-6 versus 29+/-4, P<0.001). Chronotropic incompetence was significantly more common in patients with HfpEF compare...Continue Reading

References

Feb 1, 1979·Respiration Physiology·N J Davies, D M Denison
Jun 4, 1992·The American Journal of Cardiology·G ManciaG Grassi
Oct 14, 1971·The New England Journal of Medicine·D L EckbergE Braunwald
Dec 1, 1982·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·W M SavinW L Haskell
May 1, 1995·International Journal of Cardiology·A L Clark, A J Coats
Nov 1, 1993·British Heart Journal·D Katritsis, A J Camm
Nov 1, 1996·Journal of the American College of Cardiology·A L ClarkA J Coats
Feb 18, 1999·JAMA : the Journal of the American Medical Association·M S LauerT H Marwick
Oct 28, 1999·The New England Journal of Medicine·C R ColeM S Lauer
Jan 12, 2001·Journal of the American College of Cardiology·H TanakaD R Seals
Apr 20, 2004·Journal of the American College of Cardiology·Marc KlapholzUNKNOWN New York Heart Failure Consortium
Jul 9, 2005·Progress in Cardiovascular Diseases·R Frederick Yturralde, William H Gaasch
Nov 16, 2005·Journal of the American College of Cardiology·Marco GuazziRoss Arena
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Jul 21, 2006·The New England Journal of Medicine·R Sacha BhatiaPeter P Liu
Apr 17, 2008·Circulation·Dirk WestermannCarsten Tschöpe

❮ Previous
Next ❯

Citations

Dec 9, 2010·European Heart Journal·Barry A Borlaug, Walter J Paulus
Mar 9, 2011·Circulation·Peter H Brubaker, Dalane W Kitzman
Feb 18, 2012·American Journal of Respiratory and Critical Care Medicine·Paul M Hassoun
Dec 7, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Barry A Borlaug
Mar 13, 2014·European Heart Journal·Michel Komajda, Carolyn S P Lam
Jul 1, 2014·Heart Failure Clinics·Árpád KovácsLászló Nagy
Jul 1, 2014·Heart Failure Clinics·Sanjiv J ShahRahul C Deo
Aug 12, 2014·Journal of Cardiac Failure·Nicholas E Houstis, Gregory D Lewis
Sep 14, 2014·Heart Failure Clinics·Ali Vazir, Scott D Solomon
Oct 12, 2012·Internal and Emergency Medicine·Damiano MagrìCamillo Autore
Feb 13, 2016·Journal of the American College of Cardiology·Wojciech KosmalaThomas H Marwick
Nov 30, 2013·Cardiology Clinics·Lisa J Rose-JonesPatricia P Chang
May 15, 2013·Respiratory Physiology & Neurobiology·José González-CostelloMatthew N Bartels
Mar 20, 2012·La Revue de médecine interne·P-V EnnezatS Maréchaux
Mar 11, 2015·Journal of Molecular and Cellular Cardiology·Bharathi UpadhyaDalane W Kitzman
Apr 1, 2011·Congestive Heart Failure·Krishna K GaddamHector Ventura
Mar 3, 2011·Pharmacotherapy·Megan M BarnesBarry E Bleske
Apr 28, 2012·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Shlomo Stern
Feb 26, 2016·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·A E Huis In 't VeldM L Handoko
May 28, 2014·European Journal of Heart Failure·Michael BöhmUNKNOWN I-Preserve Committees and Investigators
Mar 15, 2012·Annals of Medicine·Kannayiram AlagiakrishnanWilbert S Aronow
Jun 24, 2011·International Journal of Cardiology·David H MacIver, Mark J Dayer
Sep 4, 2010·Journal of the American College of Cardiology·Walter J Paulus
Jul 9, 2011·Journal of the American College of Cardiology·Mark J HaykowskyDalane W Kitzman
Apr 30, 2013·Seizure : the Journal of the British Epilepsy Association·Muhammet BilgiHaldun Müderrisoğlu
Dec 27, 2011·Journal of Cardiac Failure·S Michael GharacholouPatricia A Pellikka
Mar 4, 2017·Heart Failure Reviews·Stephen D FarrisApril Stempien-Otero

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.